Heteronuclear Ru(II)-Re(I) complexes as potential photodynamic anticancer agents with anti-metastatic and anti-angiogenic activities

Cyclometalated iridium(III) complexes combined with fluconazole: antifungal activity against resistant C. albicans

“…A large number of cyclomethylated iridium(III) complexes and polypyridyl ruthenium(II) complexes have been reported as enzyme inhibitors (Paȗnescu et al, 2017;He et al, 2021;Zhao et al, 2023), mitochondrial targeting agents (Guan et al, 2020;Peng et al, 2020;Qin et al, 2020;Zhang et al, 2021;Yuan et al, 2023), apoptosis (Ma et al, 2019;Zhang et al, 2022), autophagy (He et al, 2014;Chen et al, 2021), or ferroptosis inducers (Wang et al, 2020;Yuan et al, 2021). Our research group has also done some work on the anti-tumor effects of cyclometalated iridium(III) complexes and polypyridyl ruthenium(II) complexes (Lu et al, 2022b;Ma et al, 2022a;Ma et al, 2023b). Recently, we have reported a series of iridium(III) and ruthenium(II) complexes with Jumonji domain-containing protein (JMJD) histone demethylase inhibitory activity (Lu et al, 2022a;Ma et al, 2022b).…”